<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Scharler C</submitter><funding>EC | Horizon 2020 Framework Programme</funding><pagination>1246</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9666545</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(1)</volume><pubmed_abstract>Stromal cells interact with immune cells during initiation and resolution of immune responses, though the precise underlying mechanisms remain to be resolved. Lessons learned from stromal cell-based therapies indicate that environmental signals instruct their immunomodulatory action contributing to immune response control. Here, to the best of our knowledge, we show a novel function for the guanine-exchange factor DOCK2 in regulating immunosuppressive function in three human stromal cell models and by siRNA-mediated DOCK2 knockdown. To identify immune function-related stromal cell molecular signatures, we first reprogrammed mesenchymal stem/progenitor cells (MSPCs) into induced pluripotent stem cells (iPSCs) before differentiating these iPSCs in a back-loop into MSPCs. The iPSCs and immature iPS-MSPCs lacked immunosuppressive potential. Successive maturation facilitated immunomodulation, while maintaining clonogenicity, comparable to their parental MSPCs. Sequential transcriptomics and methylomics displayed time-dependent immune-related gene expression trajectories, including DOCK2, eventually resembling parental MSPCs. Severe combined immunodeficiency (SCID) patient-derived fibroblasts harboring bi-allelic DOCK2 mutations showed significantly reduced immunomodulatory capacity compared to non-mutated fibroblasts. Conditional DOCK2 siRNA knockdown in iPS-MSPCs and fibroblasts also immediately reduced immunomodulatory capacity. Conclusively, CRISPR/Cas9-mediated DOCK2 knockout in iPS-MSPCs also resulted in significantly reduced immunomodulation, reduced CDC42 Rho family GTPase activation and blunted filopodia formation. These data identify G protein signaling as key element devising stromal cell immunomodulation.</pubmed_abstract><journal>Communications biology</journal><pubmed_title>Extra-hematopoietic immunomodulatory role of the guanine-exchange factor DOCK2.</pubmed_title><pmcid>PMC9666545</pmcid><funding_grant_id>733006</funding_grant_id><pubmed_authors>Volk HD</pubmed_authors><pubmed_authors>Poupardin R</pubmed_authors><pubmed_authors>Schreck C</pubmed_authors><pubmed_authors>Strunk D</pubmed_authors><pubmed_authors>Ebner-Peking P</pubmed_authors><pubmed_authors>Krisch L</pubmed_authors><pubmed_authors>Kuchler J</pubmed_authors><pubmed_authors>Oostendorp RAJ</pubmed_authors><pubmed_authors>Brachtl G</pubmed_authors><pubmed_authors>Scharler C</pubmed_authors><pubmed_authors>Jurchott K</pubmed_authors><pubmed_authors>Daheron L</pubmed_authors><pubmed_authors>Stachelscheid H</pubmed_authors><pubmed_authors>Wolf M</pubmed_authors><pubmed_authors>Cronemberger Andrade A</pubmed_authors><pubmed_authors>Schallmoser K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Extra-hematopoietic immunomodulatory role of the guanine-exchange factor DOCK2.</name><description>Stromal cells interact with immune cells during initiation and resolution of immune responses, though the precise underlying mechanisms remain to be resolved. Lessons learned from stromal cell-based therapies indicate that environmental signals instruct their immunomodulatory action contributing to immune response control. Here, to the best of our knowledge, we show a novel function for the guanine-exchange factor DOCK2 in regulating immunosuppressive function in three human stromal cell models and by siRNA-mediated DOCK2 knockdown. To identify immune function-related stromal cell molecular signatures, we first reprogrammed mesenchymal stem/progenitor cells (MSPCs) into induced pluripotent stem cells (iPSCs) before differentiating these iPSCs in a back-loop into MSPCs. The iPSCs and immature iPS-MSPCs lacked immunosuppressive potential. Successive maturation facilitated immunomodulation, while maintaining clonogenicity, comparable to their parental MSPCs. Sequential transcriptomics and methylomics displayed time-dependent immune-related gene expression trajectories, including DOCK2, eventually resembling parental MSPCs. Severe combined immunodeficiency (SCID) patient-derived fibroblasts harboring bi-allelic DOCK2 mutations showed significantly reduced immunomodulatory capacity compared to non-mutated fibroblasts. Conditional DOCK2 siRNA knockdown in iPS-MSPCs and fibroblasts also immediately reduced immunomodulatory capacity. Conclusively, CRISPR/Cas9-mediated DOCK2 knockout in iPS-MSPCs also resulted in significantly reduced immunomodulation, reduced CDC42 Rho family GTPase activation and blunted filopodia formation. These data identify G protein signaling as key element devising stromal cell immunomodulation.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2024-11-14T23:18:37.765Z</modification><creation>2024-11-14T23:18:37.765Z</creation></dates><accession>S-EPMC9666545</accession><cross_references><pubmed>36380073</pubmed><doi>10.1038/s42003-022-04078-1</doi></cross_references></HashMap>